Welcome to BHI Therapeutic Sciences, Inc. , an international biotechnology company that specializes in delivering the highest quality stem cell treatments for various conditions. We are committed to providing our patients with the most advanced therapy at the lowest cost point in the market. BHI has a team of world-class scientists and medical professionals who are dedicated to researching and developing new treatments for a wide range of health conditions. Our research efforts are led by a Scientific Advisory Board composed of some of the most accomplished scientists and medical professionals in the field of stem cell therapy. We have a wide network of clinics located in various geographic locations across the world, each one appropriately licensed to provide the best quality of care to our patients. We are currently engaged in a U.S. FDA Investigational New Drug (IND) trial for stroke using human umbilical cord blood stem cells, which is a testament to our commitment to advancing the field of medicine. We are proud to be at the forefront of medical innovation and to be part of the future of healthcare. Our goal is to bring the benefits of stem cell therapy to as many people as possible, and we are committed to providing our patients with the best possible care.
Invest in the future of healthcare by supporting BHI Therapeutic Sciences, the US entity of the Blue Horizon International family of companies. We are proud to offer a crowdfunding opportunity for investors who are passionate about biotechnology innovation. As a leading international company, BHI provides top-quality stem cell treatments for a variety of conditions, supported by a 10-year track record of safety and efficacy. Our network of licensed clinics offers cutting-edge therapy at an affordable price, while our world-class Scientific Advisory Board conducts research efforts to advance the field of stem cell therapy. Our advisors have already successfully treated thousands of patients and we are currently involved in a U.S. FDA-approved Investigational New Drug (IND) trial for the treatment of stroke using human umbilical cord blood stem cells. Join us on the forefront of medical advancement and be a part of shaping the future of healthcare.